Roland Kappler

15PUBLICATIONS

33CO-AUTHORS

Molecular targetsHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methods

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|Jun 26, 2026

Preclinical Drug-Response Profiling Identifies BMI1 Inhibition as a Therapeutic Option for Hepatoblastoma.

|May 27, 2026

Proteasome Targeting with Carfilzomib Induces Reactive Oxygen Species-Mediated Apoptosis in Hepatoblastoma.

|Aug 14, 2025

Does Chemotherapy Have an Effect on the Treatment Success of Children and Adolescents with Unresectable Hepatocellular Carcinoma? Findings from the German Liver Tumour Registry.

Mark Rassner, Beate Häberle, Rebecca Maxwell

|Jun 04, 2025

Multiancestry Transcriptome-Wide Association Study Identifies Candidate Genes Associated with Hepatoblastoma.

Tiankai Xie, Josey C Sorenson, Logan G Spector

|Apr 26, 2025

Targeting HSP90 with Ganetespib to Induce CDK1 Degradation and Promote Cell Death in Hepatoblastoma.

Lea Amelie Jung, Salih Demir, Alina Hotes

|Nov 11, 2024

Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma.

Salih Demir, Alina Hotes, Tanja Schmid

Pageof 3

Frequent Collaborators

Stefano Cairo

Salih Demir

Carolina Armengol

Irene Schmid

Eiso Hiyama

Emilie Indersie

Adrian Gottschlich

Matthias Ilmer

Beate Häberle

Sebastian Kobold

Frequent Collaborators

Stefano Cairo

Salih Demir

Carolina Armengol

Irene Schmid